Fig. 2From: Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort studyThe dynamics of serum IL-6 in patients receiving tocilizumab (n = 16). Day 0: the day patient received the first dose of tocilizumabBack to article page